Department of Medicine, Division of Hematology and Oncology, Department of Pathology, Microbiology, and Immunology, Vanderbilt School of Medicine, Nashville, TN, USA.
Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.
Nat Immunol. 2023 Sep;24(9):1527-1539. doi: 10.1038/s41590-023-01578-y. Epub 2023 Aug 3.
Tumor-specific CD8+ T cells (TST) in patients with cancer are dysfunctional and unable to halt cancer progression. TST dysfunction, also known as exhaustion, is thought to be driven by chronic T cell antigen receptor (TCR) stimulation over days to weeks. However, we know little about the interplay between CD8 T cell function, cell division and epigenetic remodeling within hours of activation. Here, we assessed early CD8 T cell differentiation, cell division, chromatin accessibility and transcription in tumor-bearing mice and acutely infected mice. Surprisingly, despite robust activation and proliferation, TST had near complete effector function impairment even before undergoing cell division and had acquired hallmark chromatin accessibility features previously associated with later dysfunction/exhaustion. Moreover, continued tumor/antigen exposure drove progressive epigenetic remodeling, 'imprinting' the dysfunctional state. Our study reveals the rapid divergence of T cell fate choice before cell division in the context of tumors versus infection.
癌症患者的肿瘤特异性 CD8+ T 细胞(TST)功能失调,无法阻止癌症的进展。TST 功能失调,也称为衰竭,被认为是由数天到数周的慢性 T 细胞抗原受体(TCR)刺激驱动的。然而,我们对激活后数小时内 CD8 T 细胞功能、细胞分裂和表观遗传重塑之间的相互作用知之甚少。在这里,我们评估了荷瘤小鼠和急性感染小鼠中早期 CD8 T 细胞的分化、细胞分裂、染色质可及性和转录。令人惊讶的是,尽管 TST 有强烈的激活和增殖,但在细胞分裂之前,它们的效应功能几乎完全受损,并且已经获得了先前与晚期功能障碍/衰竭相关的标志性染色质可及性特征。此外,持续的肿瘤/抗原暴露导致进行性的表观遗传重塑,“印记”了功能障碍状态。我们的研究揭示了在肿瘤与感染的情况下,细胞分裂前 T 细胞命运选择的快速分歧。
Proc Natl Acad Sci U S A. 2017-3-10
J Immunother Cancer. 2019-11-5
Trends Immunol. 2025-7-23
Nat Immunol. 2025-7-23
Cancers (Basel). 2025-7-2
Biosens Bioelectron. 2025-11-1
J Immunother Cancer. 2025-5-2
Bioinformatics. 2022-4-28
Sci Immunol. 2022-2-18
Nat Rev Immunol. 2022-4